Skip to content

Clinical trials

Phase 3 Pulmonary Arterial Hypertension trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 3 Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20084
20093
20101
20111
20122
20133
20171
20181
20193
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated4
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion12
United Therapeutics6
Bayer2
Pfizer2
Aerovate Therapeutics1
Air Force Military Medical University, China1
RenJi Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension25
Hypertension, Pulmonary10
Cardiovascular Diseases2
Connective Tissue Diseases2
Eisenmenger Complex2
Familial Primary Pulmonary Hypertension2
Hypertension2
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.